Progress in the treatment of adults with acute lymphoblastic leukemia.
about
CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemiaRecurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia.A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemiasHigh frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL).Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.Comparison of temporal changes in psychological distress after hematopoietic stem cell transplantation among the underlying diseases of Japanese adult patients.High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organizedIntensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40.Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.Defined, serum/feeder-free conditions for expansion and drug screening of primary B-acute lymphoblastic leukemia.Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
P2860
Q28072550-968BA756-A064-418A-A846-73D27449D078Q33824165-0F991D8D-FE6B-461A-A53D-F778F29466FDQ34063343-DDA2BDB8-81D8-4738-A79E-0260D6EDD4C9Q34562163-BE2255E7-80C6-41D3-9A52-2B5EE56AFC02Q35723998-EE866B15-1580-421F-A8A4-177B4ECC63EFQ36243352-921CA12F-BAC7-4349-81FC-4D3ECD2B75E3Q36488188-B5699105-5026-48F2-88C5-E61F08B20C25Q37015316-A83EBF1B-9521-407D-82B5-AA1A9F843E9CQ37163738-EC54C334-5538-45FC-BB0A-64ED6F73D411Q42391671-5DEE37B6-E9AC-4E0F-8DE9-9F8B544E2157Q44232638-1B27C069-C941-4BE9-BC28-A94602417B9AQ46068589-732ED841-A140-4127-BA00-634A85DED533Q47123651-E36BD031-75E3-4F19-B6BD-4E0C4093FE5FQ53544852-D8022687-0D6C-43B3-A34A-BF8541D9714FQ54332593-19B2C878-FFE0-4337-BE7E-8E9B895A83D4Q56355417-D43DF0B5-5CAD-4DA7-83AB-2FADFD3D8474
P2860
Progress in the treatment of adults with acute lymphoblastic leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress in the treatment of adults with acute lymphoblastic leukemia.
@en
Progress in the treatment of adults with acute lymphoblastic leukemia.
@nl
type
label
Progress in the treatment of adults with acute lymphoblastic leukemia.
@en
Progress in the treatment of adults with acute lymphoblastic leukemia.
@nl
prefLabel
Progress in the treatment of adults with acute lymphoblastic leukemia.
@en
Progress in the treatment of adults with acute lymphoblastic leukemia.
@nl
P1476
Progress in the treatment of adults with acute lymphoblastic leukemia.
@en
P2093
Sarah Larson
Wendy Stock
P304
P356
10.1097/MOH.0B013E3283034697
P577
2008-07-01T00:00:00Z